PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1485869
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1485869
Biotechnology Market size was valued at USD 1.6 Trillion in 2023, expanding at a CAGR of 14.20% from 2024 to 2032.
In the multidisciplinary discipline of biotechnology, novel goods and technologies are developed through the utilization of biological systems, cells, and living beings. The technique entails utilizing molecular and cellular biological processes and creatures to tackle a range of issues in several industries, including environmental management, healthcare, and agriculture. Aiming to develop novel solutions, enhance current procedures, and deepen our understanding of living systems, biotechnology encompasses fields including genetic engineering, biopharmaceuticals, bioinformatics, and synthetic biology.
Biotechnology Market- Market Dynamics
Growing Prevalence of Chronic Diseases has Fueled the Growth of the Biotechnology Market
The incidence of chronic illnesses has increased over time, partly due to a more sedentary lifestyle that has coincided with middle-class growth and rapid urbanization. This pattern is linked to rising obesity rates and an increase in the prevalence of illnesses such as malaria, HIV, diabetes, tuberculosis, and genetic disorders. The market is further fueled by the increasing prevalence of genetic abnormalities and target diseases, continuous improvements in Polymerase Chain Reaction technology, and higher grants, financing, and investments in scientific research. With an emphasis on creating individualized therapies, the pharmacy sector is essential in preventing chronic diseases. It is anticipated that this strategy will help treat hereditary genetic illnesses and open the door for customized procedural healthcare needs. Furthermore, cutting-edge ideas like cell therapy are being brought to market and have the potential to be an effective treatment for some tumors.
Biotechnology Market- Key Insights
As per the analysis shared by our research analyst, the global Biotechnology market is estimated to grow annually at a CAGR of around 14.20% over the forecast period (2024-2032).
Based on technology segmentation, DNA sequencing segment was predicted to show maximum market share in the year 2023.
Based on application segmentation, the health segment is expected to witness the fastest growth.
On the basis of region, North America was the leading revenue generator in 2023.
The Global Biotechnology Market is segmented on the basis of Technology, Application, and Region.
The market is divided into two categories based on technology: Nanobiotechnology, Fermentation, Tissue Engineering and Regeneration, PCR Technology, DNA Sequencing, Cell-based Assays, Chromatography, and Others. The DNA sequencing category primarily led the market in 2023 due to a decrease in the cost of sequencing and an increase in the use of sophisticated DNA sequencing methods. The government's backing of genetic research has led to a surge in the applications of sequencing to better understand illnesses. For instance, an NIH grant of USD 10.7 million was awarded in May 2021 to the University of Pittsburgh Graduate School of Public Health and the Washington University School of Medicine in St. Louis for the purpose of studying the genetic basis of Alzheimer's disease.
In addition, the market is segmented into four categories based on application: Health, Natural Resources & Environment, Food & Agriculture, Bioinformatics, Industrial Processing, and Others. In 2023, the dominant segment within the market is the health category. The biotechnology industry is mostly propelled by the healthcare sector, which stimulates technological advancements that revolutionize patient care and medicine. Diagnostics, therapy development, and personalized medicine all heavily rely on biotechnology solutions. Healthcare and biotechnology work together to provide ground-breaking therapeutics, better patient outcomes, and better illness management. Examples of this collaboration include the use of advanced DNA sequencing to precisely identify diseases and the revolutionary treatment modalities offered by biopharmaceuticals.
Biotechnology Market- Geographical Insights
The biotechnology market exhibits geographical diversity across regions such as North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa, each with its unique characteristics.
North America, being a mature market, experiences high demand. The existence of major competitors, significant R&D spending, and high healthcare costs are some of the factors driving the growth of the regional industry. The use of life sciences technologies is rising in the region due to the strong penetration of platforms based on genomics, proteomics, and cell biology. Additionally, increasing acceptance of personalized medicine applications for the treatment of life-threatening conditions and the prevalence of chronic diseases are predicted to have a beneficial effect on the growth of the market in the area.
Moreover, it is projected that the Asia Pacific market will grow at the fastest rate in the forecast period. The increase in the regional market may be ascribed to favorable government efforts, rising investments and infrastructure improvements in the healthcare sector, and expansion tactics employed by major players in the industry. For instance, Moderna Inc. said in February 2022 that it intended to create four new subsidiaries in Malaysia, Singapore, Hong Kong, and Taiwan as part of its intentions to expand its commercial network throughout Asia.
Major players like Johnson & Johnson Services, Inc., Novo Nordisk A/S, Amgen Inc., Merck KGaA, Abbott Laboratories, and others are putting a lot of emphasis on strategies like product development, mergers, acquisitions, and partnerships to launch new products in order to broaden their geographic reach and bolster their product portfolio. These executives are investing in ways that allow them to receive the largest possible revenue share. The market is characterised by intense rivalry, and the top businesses rely on great products, cutting-edge technology, and a strong brand identity to increase sales. These companies use a variety of strategies, including as technological advancements, acquisitions and mergers, and research and development, to increase the range of goods they provide and maintain a competitive edge in the market.
July 2023: With the announcement of their partnership with Pfizer Inc. to acquire preclinical gene therapy initiatives, Alexion and AstraZeneca Rare Disease reaffirmed their commitment to developing next-generation genomic therapies through the integration of complementary resources and state-of-the-art technology.
June 2023: Synaffix B.V., a biotechnology business focused on developing its clinical-stage technology platform for ADC development, was acquired by Lonza. It was anticipated that Lonza's business accounts would begin to reflect Synaffix's revenues and margins as of the acquisition date.